Рак легких с помощью ИИ предложил выявлять депутат Курултая
Рак легких с помощью ИИ предложил выявлять депутат Курултая «Астана» телеарнасы
Онкология
Рак лёгких
277 материалов по теме, собраны автоматически из проверенных источников
Онкология
Рак легких с помощью ИИ предложил выявлять депутат Курултая
Рак легких с помощью ИИ предложил выявлять депутат Курултая «Астана» телеарнасы
🎗️
Онкология
Radiopharm Firm Full-Life to Launch Phase I Lung Cancer Trial in US, Australia
Radiopharm Firm Full-Life to Launch Phase I Lung Cancer Trial in US, Australia GenomeWeb
Онкология
New Mathematical model estimates curable window for fast-growing lung tumors
Detecting lung cancer early is critical to a patient's survival, but how early is early enough? Florida International University math professor and researcher Deborah Goldwasser is uncovering new findings that could identify the mathematical tipping point between curable and terminal cancer. Her work could change how…
Онкология
Bayer moves Hyrnuo into frontline lung cancer treatment
Bayer moves Hyrnuo into frontline lung cancer treatment pharmaphorum
Онкология
Guernsey charity gives university lung cancer researchers £150k
Guernsey charity gives university lung cancer researchers £150k BBC
Онкология
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer BioSpace
Онкология
Protein-based MRI agent detects lung cancer and hidden metastases earlier than current scans
A multi-institutional research team led by Georgia State University Regents' Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agents that detect invasive lung cancer and metastatic disease at earlier stages than conventional imaging…
Онкология
FDA OKs first-line Hyrnuo for non-small cell lung cancer
The FDA has granted accelerated approval to sevabertinib as first-line treatment for adults with locally advanced or metastatic non-squamous non-small cell lung cancer. The approval of sevabertinib (Hyrnuo, Bayer Healthcare Pharmaceuticals), which expands upon the agent’s existing indication for patients who received…
Онкология
Cancer's protective shield: Blocking a signaling pathway could make small cell lung tumors visible to T cells
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small cell lung cancer (SCLC) that can be exploited therapeutically.
Онкология
First-in-Class Bispecific ADC Shows Activity in Relapsed Extensive-Stage Small Cell Lung Cancer
First-in-Class Bispecific ADC Shows Activity in Relapsed Extensive-Stage Small Cell Lung Cancer ascopost.com
🎗️
Онкология
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer Oncology News Central
Онкология
Study shows how the microbiome shapes lung cancer immunotherapy outcomes - news-medical.net
Study shows how the microbiome shapes lung cancer immunotherapy outcomes news-medical.net
Онкология
Investigational Individualized Neoantigen Therapy Clinical Trials for Certain People with Lung Cancer
Investigational Individualized Neoantigen Therapy Clinical Trials for Certain People with Lung Cancer Black Doctor
Онкология
Moving the needle on lung cancer screenings: Medical students work with researchers to improve outcomes
Lung cancer is the leading cause of cancer death in the United States, claiming more than 125,000 lives each year. There is a quick, painless screening test that can detect lung cancer before symptoms appear, when treatment is more effective. Yet more than 80% of those eligible for a low-dose CT scan (LDCT) never get…